Psychiatric Times
Vol 43, Issue 6
Vol 43, Issue 5
Vol 43, Issue 4
Vol 43, Issue 3
Vol 43, Issue 2
Vol 43, Issue 1
Vol 42, Issue 12
Vol 42, Issue 11
Vol 42, Issue 10
Vol 42, Issue 9
Vol 42, Issue 8
Vol 42, Issue 7
Vol 42, Issue 6
Vol 42, Issue 5
Vol 42, Issue 4
Vol 42, Issue 3
Vol 42, Issue 2
Vol 42, Issue 1
Vol 41, Issue 12
Vol 41, Issue 11
Vol 41, Issue 10
Vol 41, Issue 9
Vol 41, Issue 8
Vol 41, Issue 7
Vol 41, Issue 6
Vol 41, Issue 5 Addiction Digital Supplement
Vol 41, Issue 5
Vol 41, Issue 4
Vol 41, Issue 3
Vol 41, Issue 2
Advertisement
Advertisement
Trending on Psychiatric Times
1
Artificial Intelligence in Psychopharmacology: Promise and Pitfalls, With Roy Perlis, MD
2
Monoamines: A Full House
3
Developing Next-Generation Psychedelic Treatments: Insights on Bretisilocin From AJ Cannon, MD
4
What Do Orexin-2 Receptor Agonists Mean for Psychiatry?
5